Table 1.
Clinicopathological Variables and circHMCU Expression in 267 Breast Cancer Patients
Variables | Classifier | Low circHMCU (n = 134) | High circHMCU (n = 133) | Total | p Value |
---|---|---|---|---|---|
Age | ≤50 | 71 | 74 | 145 | 0.755 |
>50 | 63 | 59 | 122 | ||
Menopause | no | 73 | 64 | 137 | 0.359 |
yes | 61 | 69 | 130 | ||
Histologic grade | I | 8 | 1 | 9 | |
II | 93 | 84 | 177 | 0.013 | |
III | 33 | 48 | 81 | ||
Lymph node metastasis | no | 82 | 61 | 143 | 0.017 |
yes | 52 | 72 | 124 | ||
T stage | T1 | 78 | 49 | 127 | |
T2 | 53 | 79 | 132 | 0.002 | |
T3/T4 | 3 | 5 | 8 | ||
N stage | N0 | 82 | 61 | 140 | |
N1/N2 | 51 | 65 | 122 | 0.009 | |
N3 | 1 | 7 | 5 | ||
ER | negative | 15 | 39 | 54 | <0.001 |
positive | 119 | 94 | 213 | ||
PR | negative | 24 | 42 | 66 | 0.014 |
positive | 110 | 91 | 201 | ||
HER2 | negative | 106 | 84 | 190 | 0.006 |
positive | 28 | 49 | 77 | ||
Molecular subtype | TNBC | 10 | 21 | 31 | 0.053 |
non-TNBC | 124 | 112 | 236 | ||
Ki-67 scores | low | 42 | 31 | 73 | 0.182 |
high | 92 | 102 | 194 |
T, tumor; N, node; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor-2.